Table II.

Association of BIM mean IHC scores with clinicopathological characteristics.

	N	Mean IHC score (95%CI)	p-Value
Diagnostic category			<0.001
Normal	254	0.24 (0.17–0.32)
CIN I	59	0.64 (0.39–0.89)
CIN II and III	216	3.32 (2.91–3.74)
Cervical cancer	164	2.65 (2.25–3.05)
FIGO stage			0.041
I	111	2.34 (1.88–2.80)
II	47	3.15 (2.36–3.94)
IV	6	4.50 (0.64–8.36)
Tumor differentiation			0.001
Well + Moderate	96	3.06 (2.50–3.62)
Poor	62	1.74 (1.24–2.24)
Cell Type			0.008
Squamous cell carcinoma	137	2.89 (2.46–3.32)
Others	27	1.44 (0.44–2.45)
Tumor size			0.742
<4 cm	115	2.61 (2.12–3.10)
≥4 cm	49	2.76 (2.04–3.47)
Lymphovascular invasion			0.554
Negative	81	2.56 (2.03–3.08)
Positive	66	2.32 (1.71–2.93)
Lymph node (LN) metastasis			0.213
Negative	111	2.31 (1.91–2.70)
Positive	38	2.87 (1.84–3.89)
Radiation sensitivity			0.049
Sensitive	36	3.06 (2.01–4.10)
Resistant	16	1.75 (0.91–2.59)

CIN: Cervical intraepithelial neoplasia; FIGO: International Federation of Gynecology and Obstetrics; CI: confidence interval.